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Gold sodium thiomalate, a drug used widely in the therapy of rheumatoid arthritis, was found to be an 
activator of latent human polymorphonuclear leukocyte collagenase. The activation was demonstrated by 
two distinct and independent collagenase assays: (i) by recording with a spectrophotometer at 227 nm the 
enzyme-induced increase in ultraviolet difference absorbance of native type I collagen connected to the 
cleavage of collagen at 37°C [( 1986) Eur. J. Biochem. 156, l-4] and (ii) by SDS-polyacrylamide gel electro- 
phoresis analysis of formation of specific products of collagen resulting from collagenase cleavage at 25°C. 
Activation of latent collagenase by gold sodium thiomalate appeared to be of the same magnitude as by 
the known activator phenylmercuric chloride. 
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1. INTRODUCTION 
In rheumatoid arthritis the degradation of car- 
tilage leading to erosion is believed to result from 
action of vertebrate collagenase(s) (EC 3.4.24.7). 
In clinical studies the antierosive effect of gold 
therapy has been established [1,2]. We report here 
that gold sodium thiomalate is surprisingly a po- 
tent activator of latent human leukocyte col- 
lagenase. 
2. MATERIALS AND METHODS 
Latent human leukocyte collagenase was 
purified as described [3-51. A new spec- 
trophotometric collagenase assay, recently de- 
scribed by us, based on an enzyme-induced 
increase in ultraviolet difference absorption at 
227 nm of native type I collagen in solution was us- 
ed [5]. The change in ultraviolet difference absorp- 
tion was converted to mol of collagen degraded by 
the molar difference absorbance value (AEzz,) of 
465000 1. mol-’ . cm-’ [5]. Collagenase activity 
was also measured by using SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) for separation of 
the characteristic cleavage products from intact 
parent collagen [3]. The substrate solution con- 
sisted of 1.5 PM rat type I collagen in 50 mM Tris- 
HCl, 0.2 M NaCl, 5 mM CaC12, 1 M glucose, pH 
7.5. Gold sodium thiomalate (GST) was purchased 
from Aldrich Chemie (Steinheim, FRG). 
Phenylmercuric chloride (PMC) was from EGA- 
Chemie (Steinheim/Albuch, FRG). Thiomalic acid 
was from Sigma (St. Louis, MO). All other 
chemicals were of reagent grade. 
3. RESULTS 
Latent human leukocyte collagenase was treated 
with 1.5 mM gold sodium thiomalate for 10 min at 
37°C. After this samples were added into tandem 
cuvettes and the ultraviolet difference absorption 
at 227 nm was measured [5]. Tandem cuvettes 
were used as follows: the sample to be analyzed 
was added into (i) the substrate compartment of 
the sample cuvette and (ii) the buffer compartment 
of the reference cuvette. In this way concentrations 
were equal in both the sample and reference 
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lightpaths [5]. The change in ultraviolet difference 
absorption at 227 nm was followed with a 
Beckman recording spectrophotometer model DK 
at 37°C; 10% substrate was degraded in about 
6 min (fig.lA). 
When latent collagenase was added similarly in- 
to the tandem cuvettes, no change in ultraviolet 
difference absorption occurred (fig. 1B). However, 
after addition of 1.5 mM GST, an increase in 
ultraviolet difference absorption of equal 
magnitude as in fig.lA was observed after a few 
minutes lag period (fig.lB). 
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Fig. 1. (A) Change in ultraviolet difference absorbance at 
227 nm of collagen in solution at 37°C after addition of 
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1.5 mM GST-treated leukocyte collagenase (10 ,ug 
enzyme protein). (B) Demonstration of the activation lag 
after addition of 1.5 mM GST to the mixture of latent 
leukocyte collagenase (10 pg enzyme protein) and 
collagen. 1.5 PM native type I collagen in buffer solution 
of 50 mM Tris-HCI, 0.2 M NaCl, 5 mM CaC12, 1 M 
glucose, pH 7.5, was used as a substrate. 
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Fig.2. SDS-PAGE (10%) analysis of the effect of PMC and GST on latent human leukocyte collagenase. Latent enzyme 
(10 /cg enzyme protein) was treated with buffer, 1 mM PMC and 1.5 mM GST for 10 min at 37°C and then incubated 
with 1.5 PM native type I collagen in 50 mM Tris-HCl, 0.2 M NaCI, 5 mM CarI&, 1 M glucose, pH 7.5, at 25°C for 
indicated time periods. fill and /312 indicate undegraded dimers and cul and c12 indicate undegraded monomers of 
collagen. OllA and,&l2A indicate 3/4_degradation products of dimers. cylA and cu2A indicate 3/4_degradatiqn products 
24 
of monomers; ~vlB and a2B indicate 1/4_degradation products of monomers. 
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In fig.2 the activation of latent leukocyte col- 
lagenase is followed by SDS-PAGE [3]. Without 
any activator no formation of cleavage products of 
collagen could be seen (fig.2, lanes l-4). However, 
when latent enzyme was treated with 1 mM PMC, 
known to activate latent human leukocyte col- 
lagenase [4-71, or with 1.5 mM GST, the SDS- 
PAGE analysis showed that the intact ,&- and LY- 
chains were converted to characteristic cleavage 
products ,&A-, (YA- and cuB-chains (fig.2, lanes 5-8 
for PMC; lanes 9-12 for GST), indicating that 
both compounds activated the latent enzyme. 
1.5 mM thiomalate did not activate or inhibit 
human leukocyte collagenase. 
4. DISCUSSION 
Present data indicate that GST is a potent ac- 
tivator of latent human leukocyte collagenase. The 
results also show, that the ultraviolet difference 
absorption technique [5] is a rapid and convenient 
way to study the effects of activators and/or in- 
hibitors on collagenases. 
The mechanism of activation of latent human 
leukocyte collagenase by GST is unclear, as is the 
general activation mechanism(s) of leukocyte col- 
lagenase [4,6-lo]. Latent human leukocyte col- 
lagenase can be activated by mercurial compounds 
[4,6,7], probably reacting with sulfhydryl groups 
of the latent enzyme. Organic gold (I) compounds 
have affinity towards thiol groups [11,12]; attack 
on the free sulfhydryl groups of the enzyme by the 
heavy metal may lead to activation of the enzyme 
by a conformational change [4,6], which might be 
followed by a cleavage of the polypeptide chain 
1131. 
Although variable effects of gold salts on the 
function of collagenases have been reported 
[14-161, in the conditions used by us GST-treated 
enzyme remained active for several hours. The 
significance of our finding in vivo, when the latent 
and active collagenases are exposed to a variety of 
proteases, remains to be seen. 
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